Prevention of Bleomycin-Induced Pulmonary Inflammation and Fibrosis in Mice by Bilobalide

Figure 6

Diagram depicting the regulation mechanism of bilobalide in ameliorating pulmonary fibrosis. Bilobalide inhibited inflammatory cytokines release by reducing the phosphorylation of the JNK/NF-κB pathway and the activation of NLRP3 to inhibit the inflammatory response in pulmonary fibrosis.